Lun, XueQing <br/><br/>
Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomas.  [electronic resource] 

 -  Journal of the National Cancer Institute  Nov 2006 
 - 1546-57 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1460-2105 
<br/><br/><label>Standard No.: </label>10.1093/jnci/djj413  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--administration & dosage<br/>Blotting, Western<br/>Brain Neoplasms--drug therapy<br/>Cell Line, Tumor<br/>Disease Models, Animal<br/>Fluorescent Dyes<br/>Gene Expression Regulation, Neoplastic<br/>Glial Fibrillary Acidic Protein--metabolism<br/>Glioma--drug therapy<br/>Humans<br/>Immunohistochemistry<br/>In Situ Nick-End Labeling<br/>Injections, Intravenous<br/>Luminescent Proteins<br/>Mice<br/>Mice, Nude<br/>Oncolytic Virotherapy--methods<br/>Recombinant Proteins--administration & dosage<br/>Research Design<br/>Rhabdoviridae Infections--virology<br/>Transfection<br/>Tumor Cells, Cultured<br/>Viral Matrix Proteins--administration & dosage<br/>Red Fluorescent Protein